Business Context and Reporting Period
This Form 8-K is filed by Cardio Diagnostics Holdings, Inc. (CDIO) on May 28, 2025. The report addresses a material event regarding the company's compliance with Nasdaq listing requirements.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the closing bid price of the common stock, which was $1.00 per share or greater for the 10 consecutive business days ending May 27, 2025.
Material Changes
The primary material change is the resolution of a listing deficiency. The company previously received notice on June 3, 2024, of non-compliance with Nasdaq Listing Rule 5550(a)(2) due to a closing bid price below $1.00 for 30 consecutive days. After receiving an extension to June 2, 2025, the company has now regained compliance.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of new risks. The document confirms the removal of the immediate risk of delisting due to the minimum bid price requirement.
Investor Verification Checklist
- Verify the current trading price of CDIO common stock to ensure it remains at or above the $1.00 threshold.
- Confirm the company's status on the Nasdaq Capital Market to ensure no other listing deficiencies exist.
- Review subsequent filings for any updates on the company's financial performance, as this 8-K contains no operational data.